A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1)

English version České info

Infection with Epstein-Barr virus (EBV) is highly prevalent worldwide, and it has been associated with infectious mononucleosis and severe diseases including Burkitt lymphoma, Hodgkin lymphoma, nasopharyngeal lymphoma, and lymphoproliferative disorders. Although EBV has been the focus of extensive research, much still remains unknown concerning what makes some individuals more sensitive to infection and to adverse outcomes as a result of infection. Here we use an integrative genomics approach in order to localize genetic factors influencing levels of Epstein Barr virus (EBV) nuclear antigen-1 (EBNA-1) IgG antibodies, as a measure of history of infection with this pathogen, in large Mexican American families. Genome-wide evidence of both significant linkage and association was obtained on chromosome 6 in the human leukocyte antigen (HLA) region and replicated in an independent Mexican American sample of large families (minimum p-value in combined analysis of both datasets is 1.4×10⁻¹⁵ for SNPs rs477515 and rs2516049). Conditional association analyses indicate the presence of at least two separate loci within MHC class II, and along with lymphocyte expression data suggest genes HLA-DRB1 and HLA-DQB1 as the best candidates. The association signals are specific to EBV and are not found with IgG antibodies to 12 other pathogens examined, and therefore do not simply reveal a general HLA effect. We investigated whether SNPs significantly associated with diseases in which EBV is known or suspected to play a role (namely nasopharyngeal lymphoma, Hodgkin lymphoma, systemic lupus erythematosus, and multiple sclerosis) also show evidence of associated with EBNA-1 antibody levels, finding an overlap only for the HLA locus, but none elsewhere in the genome. The significance of this work is that a major locus related to EBV infection has been identified, which may ultimately reveal the underlying mechanisms by which the immune system regulates infection with this pathogen.

Vyšlo v časopise: A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1). PLoS Genet 9(1): e32767. doi:10.1371/journal.pgen.1003147
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003147

Souhrn

Zdroje

1. CohenJI (2000) Epstein-Barr virus infection. N Engl J Med 7: 481–492.

2. BornkammGW (2009) Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue. Semin Cancer Biol 19: 351–365.

3. BabcockGJ, DeckerLL, VolkM, Thorley-LawsonD (1998) EBV persistence in memory B cells in vivo. Immunity 9: 395–404.

4. HochbergD, SouzaT, CatalinaM, SullivanJL, LuzuriagaK, et al. (2004) Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol 78: 5194–5204.

5. StevenNM (1996) Infectious mononucleosis. EBV Reports 3: 91–95.

6. de-TheG, GeserA, DayNE, TukeiPM, WilliamsEH, et al. (1978) Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274: 756–761.

7. HenleW, HenleG, HoHC, BurtinP, CachinY, et al. (1970) Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst 44: 225–231.

8. LanierAP, CliftSR, BornkammG, HenleW, GoepfertH, et al. (1991) Epstein-Barr virus and malignant lymphoepithelial lesions of the salivary gland. Arctic Med Res 50: 55–61.

9. ShibataD, TokunagaM, UemuraY, SatoE, TanakaS, et al. (1991) Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 139: 469–474.

10. WeissLM, MovahedLA, WarnkeRA, SklarJ (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320: 502–506.

11. WeissLM, StricklerJG, WarnkeRA, PurtiloDT, SklarJ (1987) Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 129: 86–91.

12. EpsteinM, WoodallJ, ThomsonA (1964) Lymphoblastic lymphoma in bone-marrow of African green monkeys (Cercopithecus aethiops) inoculated with biopsy material from a child with Burkitt's lymphoma. Lancet 2: 288–291.

13. BaerR, BankierAT, BigginMD, DeiningerPL, FarrellPJ, et al. (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310: 207–211.

14. UrayamaKY, JarrettRF, HjalgrimH, DiepstraA, KamataniY, et al. (2012) Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst 104: 240–253.

15. HjalgrimH, RostgaardK, JohnsonPCD, LakeA, ShieldL, et al. (2010) HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci USA 107: 6400–6405.

16. DiepstraA, NiensM, VellengaE, van ImhoffGW, NolteIM, et al. (2005) Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma. Lancet 365: 2216–2224.

17. McAulayKA, HigginsCD, MacsweenKF, LakeA, JarrettRF, et al. (2007) HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest 117: 3042–3048.

18. SundqvistE, SundströmP, LindénM, HedströmAK, AloisiF, et al. (2012) Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun 13: 14–20.

19. SundströmP, NyströmL, JidellE, HallmansG (2008) EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study. Mult Scler 14: 1120–1122.

20. SpenceA, WestlakeJ, LangeK (1977) Estimation of the variance components for dermal ridge count. Ann Hum Genet 41: 111–115.

21. RubiczR, LeachCT, KraigE, DhurandharNV, DuggiralaR, et al. (2011) Genetic factors influence serological measures of common infections. Hum Hered 72: 133–141.

22. PuppalaS, DoddGD, FowlerS, AryaR, SchneiderJ, et al. (2006) A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am J Hum Genet 78: 377–392.

23. RubiczR, LeachCT, KraigE, DhurandharNV, GrubbsB, et al. (2011) Seroprevalence of 13 common pathogens in a rapidly growing U.S. minority population: Mexican Americans from San Antonio, TX. BMC Res Notes 21: 433.

24. Rickinson AB, Kieff E (2001) Epstein-Barr virus. In Field's Virology, Knipe, D.M., Howley P.M., Griffin, DE. Martin, M.A., Lamb, R.A., and Roizman, B., ed. (Philadelphia, PA: Lippincott Williams & Wilkins).

25. De PaschaleM, AgrappiC, MancoMT, MirriP, ViganòEF, et al. (2009) Seroepidemiology of EBV and interpretation of the “isolated VCA IgG” pattern. J Med Virol 81: 325–331.

26. PorterDD, WimberlyI, Benyesh-MelnickM (1969) Prevalence of antibodies to EB virus and other herpesviruses. JAMA 208: 1675–1679.

27. BessonC, AmielC, Le-PendevenC, PlancoulaineS, RanqueB, et al. (2009) Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas. J Infect Dis 199: 1121–1127.

28. NemerowGR, MoldC, SchwendVK, TollefsonV, CooperNR (1987) Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol 61: 1416–1420.

29. LiQ, SpriggsMK, KovatsS, TurkSM, ComeauMR, et al. (1997) Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 71: 4657–4662.

30. KhanG, MiyashitaEM, YangB, BabcockGJ, Thorley-LawsonDA (1996) Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5: 173–179.

31. Nebel-SchickelH, HindererW, SaavedraC, SchmutzlerR, HornJ, et al. (1994) Anti-EBNA-1 (carboxy-half) IgG antibodies as a seroepidemiological marker for Epstein-Barr virus infection. Beitr Infusionsther Transfusionsmed 32: 134–137.

32. LevitskayaJ, SharipoA, LeonchiksA, CiechanoverA, MasucciMG (1997) Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 94: 12616–12621.

33. ZengY, JanMG, ZhangQ, ZhangLG, LiHY, et al. (1982) Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 29: 139–141.

34. PathmanathanR, PrasadU, SadlerR, FlynnK, Raab-TraubN (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333: 693–698.

35. GlaserSL, GulleyML, ClarkeCA, KeeganTH, ChangET, et al. (2008) Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. Int J Cancer 123: 1499–1507.

36. NourseJP, JonesK, GandhiMK (2011) Epstein-Barr Virus-related post-transplant lymphoproliferative disorders: pathogenic insights for targeted therapy. Am J Transplant 11: 888–895.

37. HenleG, HenleW, CliffordP, DiehlV, KafukoGW, et al. (1969) Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst 43: 1147–1157.

38. JamesJA, HarleyJB, ScofieldRH (2006) Epstein-Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol 18: 462–467.

39. AscherioA, MungerKL, LennetteET, SpiegelmanD, HernanMA, et al. (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286: 3083–3088.

40. ArbuckleMR, ReichlinM, HarleyJB, JamesJA (1999) Shared early autoantibody recognition events in the development of anti-Sm B/B' in human lupus. Scand J Immunol 50: 447–455.

41. PooleBD, ScofieldRH, HarleyJB, JamesJA (2006) Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39: 63–70.

42. FernandoMMA, FreudenbergJ, LeeA, MorrisDL, BotevaL, et al. (2012) Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G. Ann Rheum Dis Epub Jan 10.

43. LincolnMR, MontpetitA, CaderMZ, SaarelaJ, DymentDA, et al. (2005) A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 37: 1108–1112.

44. HandelAE, HandunnetthiL, BerlangaAJ, WatsonCT, MorahanJM, et al. (2010) The effect of single nucleotide polymorphisms from genome wide association studies in multiple sclerosis on gene expression. PLoS ONE 5: e10142 doi:10.1371/journal.pone.0010142.

45. MitchellBD, KammererCM, BlangeroJ, MahaneyMC, RainwaterDL, et al. (1996) Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 9: 2159–2170.

46. HuntKJ, LehmanDM, AryaR, FowlerS, LeachRJ, et al. (2005) Genome-wide linkage analyses of type 2 diabetes in Mexican Americans: the San Antonio Family Diabetes/Gallbladder Study. Diabetes 54: 2655–2662.

47. McPeekMS, SunL (2000) Statistical tests for detection of misspecified relationships by use of genome-screen data. Am J Hum Genet 66: 1076–1094 (2000).

48. ChengML, WoodfordSC, HilburnJL, VandeBergJL (1986) A novel system for storage of sera frozen in small aliquots. J Biochem Biophys Methods 1: 47–51.

49. DhurandharNV, IsraelBA, KolesarJM, MayhewGF, CookME, et al. (2000) Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disor 24: 989–996.

50. AlmasyL, BlangeroJ (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62: 1198–1211.

51. SobelE, PappJC, LangeK (2002) Detection and integration of genotyping errors in statistical genetics. Am J Hum Genet 70: 496–508.

52. AbecasisGR, ChernySS, CooksonWO, CardonLR (2002) Merlin–rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30: 97–101.

53. HeathSC (1997) Markov chain Monte Carlo segregation and linkage analysis for oligogenic models. Am J Hum Genet 61: 748–760.

54. KongA, GudbjartssonDF, SainzJ, JonsdottirGM, GudjonssonSA, et al. (2002) A high-resolution recombination map of the human genome. Nat Genet 31: 241–247.

55. DuggiralaR, WilliamsJT, Williams-BlangeroS, BlangeroJ (1997) A variance component approach to dichotomous trait linkage analysis using a threshold model. Genet Epidemiol 6: 987–992.

56. WilliamsJT, Van EerdeweghP, AlmasyL, BlangeroJ (1999) Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. I. Likelihood formulation and simulation results. Am J Hum Genet 4: 1134–1147.

57. PriceAL, PattersonNJ, PlengeRM, WeinblattME, ShadickNA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904–909.

58. R Development Core Team (2011). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/.

59. PruimRJ, WelchRP, SannaS, TeslovichTM, ChinesPS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336–2337.

60. GöringHHH, CurranJE, JohnsonMP, DyerTD, CharlesworthJ, et al. (2007) Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat Genet 10: 1208–1216.

61. NgCC, YewPY, PuahSM, KrishnanG, YapLF, et al. (2009) A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet 54: 392–397.

62. BeiJX, LiY, JiaWH, FengBJ, ZhouG, et al. (2010) A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 42: 599–603.

63. TseKP, SuWH, ChangKP, TsangNM, YuCJ, et al. (2009) Genome-wide association study reveals multiple nasopharyngeal carcinoma-associateed loci within the HLA region at chromosome 6p21.3. Am J Hum Genet 85: 194–203.

64. ZhaoM, CaiH, LiX, ZhengH, YangX, et al. (2010) Further evidence for the existence of major susceptibility of nasopharyngeal carcinoma in the region near HLA-A locus in Southern Chinese. J Transl Med 10: 57.

65. JiaWH, PanHQ, QinHD, XuYF, ShenGP, et al. (2009) A case-control and family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese. Carcinogenesis 30: 2031–2036.

66. QinHD, ShugartYY, BeiJX, PanQH, ChenL, et al. (2011) Comprehensive pahtway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. Cancer Res 71: 3000–3008.

67. Encisco-MoraV, BroderickP, MaY, JarrettRF, HjalgrimH, et al. (2010) A genome-wide association of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet 42: 1126–1130.

68. UrayamaKY, JarrettRF, HjalrimH, DiepstraA, KamataniY, et al. (2012) Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status defined subgroups. JNCI 104: 240–253.

69. CozenW, LiD, BestT, Van Den BergDJ, GourraudPA, et al. (2012) A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32. Blood 119: 469–475.

70. GatevaV, SandlingJK, HomG, TaylorKE, ChungSA, et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41: 1228–1233.

71. International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN) (2008) HarleyJB, Alarcón-RiquelmeME, CriswellLA, JacobCO, et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40: 204–210.

72. KyogokuC, LangefeldCD, OrtmannWA, LeeA, SelbyS, et al. (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75: 504–507.

73. KarassaFB, TrikalinosTA, IoannidisJP (2002) Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum 46: 563–1571.

74. EdbergJC, LangefeldCD, WuJ, MoserKL, KaufmanKM, et al. (2002) Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum 46: 2132–2140.

75. HanJW, ZhengHF, CuiY, SunLD, YeDQ, et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41: 1234–1237.

76. Cunninghame GrahamDS, GrahamRR, MankuH, WongAK, WhittakerJC, et al. (2008) Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat Genet 40: 83–89.

77. CunninghameG, MorrisDL, BhangaleTR, CriswellLA, SyvänenAC, et al. (2011) Association of NCF2, IKZF1, IRF8, and TYK2 with systemic lupus erythematosus. PLoS Genet 7: e1002341 doi:10.1371/journal.pgen.1002341.

78. HomG, GrahamRR, ModrekB, TaylorKE, OrtmannW, et al. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358: 900–909.

79. GrahamRR, CotsapasC, DaviesL, HackettR, LessardCJ, et al. (2008) Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 40: 1059–1061.

80. Suarez-GestalM, CalazaM, EndreffyE, PullmannR, Ordi-RosJ, et al. (2009) Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther 11: R69.

81. NamjouB, KothariPH, KellyJA, GlennSB, OjwangJO, et al. (2011) Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 12: 270–279.

82. Lee-KirschMA, GongM, ChowdhuryD, SenenkoL, EngelK, et al. (2007) Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39: 1065–1067.

83. KozyrevSV, AbelsonAK, WojcikJ, ZaghloolA, Linga ReddyMV, et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 40: 211–216.

84. YuB, ChenY, WuQ, LiP, ShaoY, et al. (2011) The association between single-nucleotide polymorphisms of NCF2 and systemic lupus erythematosus in Chinese mainland population. Clin Rheumatol 30: 521–527.

85. HughesT, Kim-HowardX, KellyJA, KaufmanKM, LangefeldCD, et al. (2011) Fine mapping and transethnic geotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. Arthritis Rheum 63: 1689–1697.

86. FernandoMM, FreudenbergJ, LeeA, MorrisDL, BotevaL, et al. (2012) Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G. Ann Rheum Dis 71: 777–784.

87. BarcellosLF, MaySL, RamsayPP, QuachHL, LaneJA, et al. (2009) High density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet 5: e1000696 doi:10.1371/journal.pgen.1000696.

88. ZhangY, YangW, MokCC, ChanTM, WongRW, et al. (2011) Two missense variants in UHRF1BP1 are independently associated with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun 12: 231–234.

89. MusoneSL, TaylorKE, LuTT, NitithamJ, FerreiraRC, et al. (2008) Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 40: 1062–1064.

90. SigurdssonS, GöringHH, KristjansdottirG, MilaniL, NordmarkG, et al. (2008) Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet 17: 872–881.

91. SigurdssonS, PadyukovL, KurreemanFA, LijedahlU, WimanAC, et al. (2007) Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 56: 2202–2210.

92. SigurdssonS, NordmarkG, GöringHH, LindroosK, WimanAC, et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76: 528–537.

93. GrahamRR, KozyrevSV, BaechlerEC, ReddyMV, PlengeRM, et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38: 550–555.

94. BudarfML, GoyetteP, BoucherG, LianJ, GrahamRR, et al. (2011) A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes Immun 12: 51–58.

95. LuR, VidalGS, KellyJA, Delgado-VegaAM, HowardXK, et al. (2009) Genetic associations of LYN with systemic lupus erythematosus. Genes Immun 10: 397–403.

96. RamosPS, CriswellLA, MoserKL, ComeauME, WilliamsAH, et al. (2011) A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet 7: e1002406 doi:10.1371/journal.pgen.1002406.

97. LessardCJ, AdriantoI, KellyJA, KaufmanKM, GrundahlKM, et al. (2011) Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet 88: 83–91.

98. YangJ, YangW, HirankarnN, YeDQ, ZhangeY, et al. (2011) ELF1 is associated with systemic lupus erythematosus in Asian populations. Hum Mol Genet 20: 601–607.

99. ShengYJ, GaoJP, LiJ, HanJW, XuQ, et al. (2011) Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus. Rheumatology 50: 682–688.

100. YangW, ShenN, YeDQ, LiuQ, ZhangY, et al. (2010) Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 6: e1000841 doi:10.1371/journal.pgen.1000841.

101. MolinerosJE, Kim-HowardX, DeshmukhH, JacobCO, HarleyJB, et al. (2009) Admixture in Hispanic Americans: its impact on ITGAM association and implications for admixture mapping in SLE. Genes Immun 10: 539–545.

102. VazgiourakisVM, ZervouMI, ChoulakiC, BertsiasG, MelissourgakiM, et al. (2011) A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis. Ann Rheum Dis 70: 2184–2190.

103. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 41: 824–828.

104. De JagerPL, JiaX, WangJ, de BakkerPI, OttoboniL, et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41: 776–782.

105. BaranziniSE, WangJ, GibsonRA, GalweyN, NaegelinY, et al. (2009) Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 18: 767–778.

106. GregorySG, SchmidtS, SethP, OksenbergJR, HartJ, et al. (2007) Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39: 1083–91.

107. ComabellaM, CraigDW, Camiña-TatoM, MorcilloC, LopezC, et al. (2008) Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS ONE 3: e3490 doi:10.1371/journal.pone.0003490.

108. International Multiple Sclerosis Genetics Consortium (2007) HaflerD, CompostonA, SawcerS, LanderES, et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357: 851–862.

109. JakkulaE, LeppäV, SulonenAM, VariloT, KallioS, et al. (2010) Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 86: 285–291.

110. NischwitzS, CepokS, KronerA, WolfC, KnopM, et al. (2010) Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. J Neuroimmunol 227: 162–166.